Resultados de la búsqueda 41-50 of 5584 for Toplist Nghệ An

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. Adding ...

  2. Médicos - Medicina de laboratorio y patología - Mayo Clinic

    Nikola A. Baumann, Ph.D. Rochester, MN.

  3. Síntomas y causas - Mayo Clinic

    B-cell lymphomas are a type of lymphoma. Lymphoma is cancer that affects the lymphatic system. The lymphatic system is made up of organs, glands, tubelike ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns of ...

  7. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Top 10 questions about breast cancer answered Oct. ... Mayo Clinic launches Rainbows, an LGBTQ-focused ... a mastectomy April 18, 2023, 01:30 p.m. CDT.

  8. Cáncer del intestino delgado - Médicos y departamentos - Mayo Clinic

    Connect with others like you for support and answers to your questions in the Colorectal Cancer support group on Mayo Clinic Connect, a patient community.

  9. Chlamydia trachomatis - Diagnóstico y tratamiento - Mayo Clinic

    Esta infección de transmisión sexual común puede conducir a graves problemas de salud si no se trata. Obtén más información sobre los síntomas, ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...